Hyper-reduced grafts in living donor liver transplant: Techniques and outcomes

Table 2 Indications for liver transplantation among the studies

Ref.	Indications
Strong et al[24]	Biliary atresia, re-transplantation and hepatic artery thrombosis (n = 1)
Mentha et al[25]	Biliary atresia and re-transplantation (n = 1)
Srinivasan et al[14]	Fulminant hepatic failure (n = 5), re-transplantation and hepatic artery thrombosis (n = 1)
Noujaim et al[26]	Fulminant hepatic failure (n = 2)
Kasahara et al[8]	Biliary atresia (n = 8), fulminant hepatic failure (n = 4) and hepatic artery thrombosis (n = 2)
Attia et al[27]	Fulminant hepatic failure (n = 1), biliary atresia (n = 1), medial reduction (n = 1) and re-transplantation (n = 1)
Grabhorn et al[32]	Fulminant hepatic failure (n = 10)
Enne et al[28]	Biliary atresia (n = 12)
Thomas et al[30]	Biliary atresia (n = 9)
Shehata et al[3]	Biliary atresia (n = 24), fulminant hepatic failure (n = 16) and medial reduction (n = 4)
Kanazawa et al[2]	Biliary atresia (n = 18), fulminant hepatic failure (n = 7) and medial reduction (n = 4)
Sakamoto et al[20]	Biliary atresia (n = 4) and methyl malonic acidaemia (n = 1)
Sanada et al[31]	Fulminant hepatic failure (n = 8), biliary atresia (n = 2) and others (n = 3)
Kitajima et al[29]	Biliary atresia (n = 50), fulminant hepatic failure (n = 17) and others (n = 22)
Raices et al[33]	Biliary atresia (n = 46), Alagille syndrome (n = 6) and others (n = 7)
Hirata et al[34]	Biliary atresia (n = 25)
Zakaria et al[35]	Biliary atresia (n = 28), progressive familial intrahepatic cholestasis (type I, II, III, IV) (n = 15), sclerosing cholangitis (n = 4), Alagille syndrome (n = 3), Crigler-Najjar syndrome (n = 2), Neonatal hemochromatosis (n = 3), Tyrosinaemia (n = 2) Congenital hepatic fibrosis (n = 1) Argininosuccinic aciduria (n = 1), Caroli disease (n = 4), Mitochondrial hepatopathy (n = 2) Fragile X syndrome (n = 1) and Cryptogenic cirrhosis (n = 4)
Malla et al[36]	Alloimmune hepatitis (n = 2), biliary atresia (n = 4) and acute liver failure (n = 1)